Bioptix appoints Michael Beeghley new CEO
CASTLE ROCK -- Bioptix, Inc. (Nasdaq: BIOP) announced its board of directors has appointed Michael M. Beeghley as CEO effective April 6, 2017. Beeghley succeeds Steve Lundy , who resigned... Read More
Wednesday April 12, 2017
Venaxis changes name to Bioptix, symbol to BIOP
BOULDER --Venaxis Inc. (Nasdaq: APPY), announced it is changing the companys name to Bioptix Inc . following approval from shareholders at the 2016 annual meeting of shareholders. The... Read More
Monday December 12, 2016
Venaxis announces acquisition of BiOptix
CASTLE ROCK -- Venaxis Inc. (Nasdaq: APPY), today announced it has acquired Boulder-based BiOptix Diagnostics, Inc. ("BiOptix"), a privately held company. Venaxis has developed a proprietary... Read More
Wednesday September 14, 2016
BiOptix technology added to XTAL BioStructures’ suite of biophysical tools
BOULDER -- BiOptix , a life science tools company providing an affordable and powerful solution for drug discovery scientists who require label-free, real-time detection of biomolecular... Read More
Wednesday September 23, 2015
MoneyTree Report: Venture capital investment in Colorado rose significantly in '14
WASHINGTON, D.C. -- Venture capital investment in Colorado nearly doubled from 2013 to 2014, according to a recently released MoneyTree report from Pricewaterhouse Coopers. The report said... Read More
Monday April 20, 2015
BiOptix expands leadership team, appoints Dr. Scott Klakamp VP of chemistry, biochemistry
BOULDER -- BiOptix has appointed Dr. Scott Klakamp as the company's VP of chemistry and biochemistry. Klakamp joins the company after previous scientific leadership positions at Takeda... Read More
Monday January 26, 2015
BiOptix taps Ken Dickerson to lead company's sales efforts
BOULDER - BiOptix has announced the appointment of Ken Dickerson as VP of sales. Dickerson most recently served as national sales director for ACEA Biosciences. He has also held sales... Read More
Monday January 19, 2015
BiOptix receives $1.4M funding infusion from existing investors to speed commercial success
BOULDER - BiOptix announced it received an additional $1.4 million in financing from existing investors that will be used to expand sales and marketing and ramp up manufacturing to meet... Read More
Friday August 15, 2014
IN Sponsors
Browse
Entrepreneurial by Nature
